Successful virologic outcomes over time among HAART-treated HIV-infected patients

References

• Corral, J., David, N., Moyle, G., & Mancini, M. (2008). Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. Lancet, 372(9639), 646–655. https://doi.org/10.1016/S0140-6736(08)61081-8
   PubMed Web of Science ®Google Scholar
• Delaugerre, C., Ghosn, J., Lacombe, J. M., Pialoux, G., Cuzin, L., Launay, O., Menard, A., De, T. P., & Costagliola, D. (2015). Significant reduction in HIV virologic failure during a 15-year period in a setting With free healthcare access. Clinical Infectious Diseases, 60(3), 463–472. https://doi.org/10.1093/cid/ciu834
   PubMed Web of Science ®Google Scholar
• Deschamps, A., De-Geest, S. A., Bobbaers, H., Peetermans, W., & Van-Wijngaerden, E. (2008). Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care & Stds, 22(9), 735–743. https://doi.org/10.1089/apc.2007.0229
   PubMed Web of Science ®Google Scholar
• Gill, V. S., & Vdzhang, L. (2010). Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. Clinical Infectious Diseases, 50(1), 98–105. https://doi.org/10.1086/648729
   PubMed Web of Science ®Google Scholar
• Gross, R., Yip, B., Re Iii, V. L., Wood, E., Alexander, C. S., Harrigan, P. R., Bangsberg, D. R., Montaner, J. S. G., & Hogg, R. S. (2006). A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. Journal of Infectious Diseases, 194(8), 1108–1114. https://doi.org/10.1086/507680
   PubMed Web of Science ®Google Scholar
• Grossberg, R., Zhang, Y., & Gross, R. (2004). A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. Journal of Clinical Epidemiology, 57(10), 1107–1110. https://doi.org/10.1016/j.jclinepi.2004.04.002
   PubMed Web of Science ®Google Scholar
• Hailu, G. G., Hagos, D. G., Hagos, A. K., Wasihun, A. G., & Dejene, T. A. (2018). Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the tigray region of northern Ethiopia. PLoS One, 13(5), 1–17. https://doi.org/10.1371/journal.pone.0196259
   Web of Science ®Google Scholar
• Hogg, R. S., Katherine, H., David, B., Benita, Y., Natasha, P., O'Shaughnessy, M. V., & Montaner, J. S. G. (2002). Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. Aids (london, England), 16(7), 1051–1058. https://doi.org/10.1097/00002030-200205030-00012
   PubMed Web of Science ®Google Scholar
• Karade, S. K., Ghate, M. V., Chaturbhuj, D. N., Kadam, D. B., Shankar, S., Gaikwad, N., Gurav, S., Joshi, R., Sane, S. S., & Kulkarni, S. S. (2016). Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in western India. Medicine, 95(37), 1–10. https://doi.org/10.1097/MD.0000000000004886
   Web of Science ®Google Scholar
• Klimas, N., Koneru, A. O., & Fletcher, M. A. (2008). Overview of HIV. Psychosomatic Medicine, 70(5), 523–530. https://doi.org/10.1097/PSY.0b013e31817ae69f
   PubMed Web of Science ®Google Scholar
• Kuritzkes, D. R. (2004). Preventing and managing antiretroviral drug resistance [Journal Article; Research Support, Non-U.S. Gov't; review]. AIDS Patient Care and STDs, 18(5), 259–273. https://doi.org/10.1089/108729104323076007
   PubMed Web of Science ®Google Scholar
• Lampe, F. C., Smith, C. J., Sara, M., Sabine, K. D. L., Mervyn, T., Sabin, C. A., Clinton, C., Mike, Y., Johnson, M. A., & Phillips, A. N. (2007). Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004. Archives of Internal Medicine, 167(7), 692–700. https://doi.org/10.1001/archinte.167.7.692
   PubMedGoogle Scholar
• Ledergerber, B., Cavassini, M., Battegay, M., Bernasconi, E., Vernazza, P., Hirschel, B., Furrer, H., Rickenbach, M., Weber, R., & Study, S. H. C. (2011). Trends over time of virological and immunological characteristics in the Swiss HIV cohort study. HIV Medicine, 12(5), 279–288. https://doi.org/10.1111/j.1468-1293.2010.00880.x
   PubMed Web of Science ®Google Scholar
• Liang, Z., Ye, M., Dou, Z., Zhao, D., & Zhang, F. (2016). Study on the survival of adult HIV/AIDS patients received antiretroviral therapy before and after the adjustment of enrollment criteria[In Chinese]. Chinese Journal of Aids & Std, 22(07), 488–492. https://doi.org/10.13419/j.cnki.aids.2016.07.02
   Google Scholar
• Liao, L., Xing, H., Su, B., Wang, Z., Ruan, Y., Wang, X., Liu, Z., Lu, Y., Yang, S., Zhao, Q., Vermund, S. H., Chen, R. Y., & Shao, Y. (2013). Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China [Journal Article; Research Support, Non-U.S. Gov't]. Aids (london, England), 27(11), 1815–1824. https://doi.org/10.1097/QAD.0b013e3283611931
   PubMed Web of Science ®Google Scholar
• Lima, V. D., Bangsberg, D. R., Harrigan, P. R., Deeks, S. G., Yip, B., Hogg, R. S., & Montaner, J. S. (2010). Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. JAIDS Journal of Acquired Immune Deficiency Syndromes, 55(4), 460–465. https://doi.org/10.1097/QAI.0b013e3181f2ac87
   PubMed Web of Science ®Google Scholar
• Liu, P., Liao, L., Xu, W., Yan, J., Zuo, Z., Leng, X., … Shao, Y. (2018). Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015. Medicine, 97(50), 1–7. https://doi.org/10.1097/MD.0000000000013555
   Web of Science ®Google Scholar
• Martin, D. A., Luz, P. M., Lake, J. E., Clark, J. L., Veloso, V. G., Moreira, R. I., Cardoso, S. W., Klausner, J. D., & Grinsztejn, B. (2014). Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de janeiro, 1997–2011. BMC Infectious Diseases, 14(1), 1–10. https://doi.org/10.1186/1471-2334-14-322
   PubMedGoogle Scholar
• Moore, R. D., & Bartlett, J. G. (2011). Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. Clinical Infectious Diseases, 53(6), 600–604. https://doi.org/10.1093/cid/cir467
   PubMed Web of Science ®Google Scholar
• Mugavero, M. J., Raper, J. L., Reif, S., Whetten, K., Leserman, J., Thielman, N. M., & Pence, B. W. (2009). Overload: The impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multi-site HIV cohort study. Psychosomatic Medicine, 71(9), 920–926. https://doi.org/10.1097/PSY.0b013e3181bfe8d2
   PubMed Web of Science ®Google Scholar
• Nachega, J. B., Hislop, M., Dowdy, D. W., Chaisson, R. E., Regensberg, L., & Maartens, G. (2007). Adherence to nonnucleoside reverse transcriptase inhibitor–based HIV therapy and virologic outcomes. Annals of Internal Medicine, 146(8), 564–573. https://doi.org/10.7326/0003-4819-146-8-200704170-00007
   PubMed Web of Science ®Google Scholar
• Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30. https://doi.org/10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Penot, P., Héma, A., Bado, G., Kaboré, F., Soré, I., Sombié, D., … Laurent, C. (2014). The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso. Journal of the International AIDS Society, 17(1), 1–7. https://doi.org/10.7448/IAS.17.1.18646
   Google Scholar
• Ryscavage, P. A., Anderson, E. J., Sutton, S. H., Reddy, S., & Taiwo, B. (2011). Clinical outcomes of adolescents and young adults in adult HIV care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 58(2), 193–197. https://doi.org/10.1097/QAI.0B013E31822D7564
   PubMed Web of Science ®Google Scholar
• Sidibé, M. (2014). Fast-track – Ending the AIDS epidemic by 2030.
   Google Scholar
• Tariku, A., Bayu, B., Bulti, A. B., Habitu, Y. A., Derso, T., & Teshome, D. F. (2017). Determinants of virological failure among patients on highly active antiretroviral therapy in University of gondar referral hospital. Northwest Ethiopia: a Case–Control Study. Hiv/Aids, 9, 153–159. https://doi.org/10.2147/HIV.S139516
   Google Scholar
• The lancet. HIV. (2017). U = U taking off in 2017. The Lancet. HIV, 4(11), 1–1. https://doi.org/10.1016/S2352-3018(17)30183-2
   Web of Science ®Google Scholar
• Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., … Volberding, P. A. (2012). Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International antiviral society–USA panel. JAMA, 308(4), 387–402. https://doi.org/10.1001/jama.2012.7961
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach (pp. 132). World Health Organization.
   Google Scholar
• Xuebing, L., Shujia, L., Yanling, M., Yonghui, D., Wei, K., Daniel, G., Hsi, J. H., Lingjie, L., Jing, W., & Cui, H. (2014). HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China. BMJ Open, 4(10), 1–7. http://doi.org/10.1136/bmjopen-2014-005886
   Web of Science ®Google Scholar
• Yehia, B. R., Fleishman, J. A., Metlay, J. P., Moore, R. D., & Gebo, K. A. (2012). Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA, 308(4), 339–342. https://doi.org/10.1001/jama.2012.5927
   PubMed Web of Science ®Google Scholar
• Zhang, F., Dou, Z., Ma, Y., Zhang, Y., Zhao, Y., Zhao, D., … Chen, R. Y. (2011). Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: A national observational cohort study. The Lancet Infectious Diseases, 11(7), 516–524. https://doi.org/10.1016/S1473-3099(11)70097-4
   PubMed Web of Science ®Google Scholar